tickers.watch
PerpsTokenized
EventsListings
tickers.watch
PerpsTokenized
EventsListings
back

LLY

Stock·CLOSEDNYSE/NASDAQTokenized →

Eli Lilly and Company: Pharma leader in diabetes and weight-loss drugs (Mounjaro, Zepbound).

No instruments match the current filters.

Price
1,154.74
24H
—
Volume 24h
$1.89M
OI (USD)
$21.5M
Market Cap
$1.09T
ExchangeSymbolMarkIndexBasisFundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume.Volume 24hVol %OI (USD)Live
LLYUSDT1,155.271,155.27+0.0 bps--:--:--+0.0000%(+0.00% ann)$738.85K39.0%$2.13M110d
LLYUSDT1,154.641,154.64+0.0 bps--:--:--+0.0000%(+0.00% ann)$405.5K21.4%$1.31M131d
LLY-USDT-SWAP1,154.401,155.26-7.4 bps--:--:--+0.0000%(+0.00% ann)$259.29K13.7%$792.58K145d
LLY_USDT1,154.111,154.12-0.1 bps--:--:--+0.0000%(+0.00% ann)$215.66K11.4%$1.3M233d
xyzLLY-USDC1,153.501,153.80-2.6 bps--:--:--+0.0006%(+5.47% ann)$139.19K7.4%$8.65M184d
LLYSTOCK_USDT1,155.371,154.67+6.1 bps--:--:--+0.0000%(+0.00% ann)$80.59K4.3%$5.07M193d
LLYUSDT1,154.811,154.79+0.1 bps--:--:--+0.0000%(+0.00% ann)$53.19K2.8%$2.25M313d

News

14
  • LLY▲Eli Lilly wins second FDA approval for Inluriyo after doubling progression-free survivalLLY▲

    1d
  • NVOLLYTSLA▲Wegovy approved in China as first and only GLP-1 for MASH treatmentNVOLLYTSLA▲

    ×39d
  • PFEMRKLLY▼US Health Secretary: New drug pricing agreement includes $19.6 billion to bring production back to the US.PFEMRKLLY▼

    ×219d
  • LLY▼Eli Lilly plans to acquire Merida Biosciences for up to $2.875 billion in cash, expected to close in Q4.LLY▼

    ×219d
  • LLYNVO▼Trump's low-cost weight-loss drug plan faces cold reception, most states' Medicaid refuses to pay for GLP-1 drugsLLYNVO▼

    28d

Related tickers

SNDKSanDiskSKHYNIXSK Hynix (Korean Common)MSTRMicroStrategyMUMicron TechnologyCRCLCircle InternetSPCXSpaceXSKHYSK Hynix (ADR)TSLATesla, Inc.SMSNSamsung ElectronicsNVDANVIDIAINTCIntelAAPLApple
tickers.watch
AboutPrivacylisting.watch© 2026 ICG Trading. All rights reserved.